Tom Powles (@tompowles1) 's Twitter Profile
Tom Powles

@tompowles1

Interested in Urology Cancers, biomarkers and drug development.

ID: 1206580727296544769

calendar_today16-12-2019 14:24:22

1,1K Tweet

12,12K Takipçi

62 Takip Edilen

Tom Powles (@tompowles1) 's Twitter Profile Photo

Bladder cancer #ASCO25 1) Ipi/nivo vs 1st line chemo (HR 0.79)-near miss 2) maintenance SG/PD-L1 vs PD-L1 (PFS HR0.49)-still relevant? 3) CIS subset analysis for salanlimab in NMIBC-pt selection for therapy? 4) A new Nectin4 ADC 9MW/PD1 in phase II RR=88%! 5) EVP update on RR/tox

Bladder cancer #ASCO25 1) Ipi/nivo vs 1st line chemo (HR 0.79)-near miss 2) maintenance SG/PD-L1 vs PD-L1 (PFS HR0.49)-still relevant? 3) CIS subset analysis for salanlimab in NMIBC-pt selection for therapy? 4) A new Nectin4 ADC 9MW/PD1 in phase II RR=88%! 5) EVP update on RR/tox